急诊科中度程序性镇静中丙泊酚与阿芬太尼的随机临床试验
该随机临床试验在急诊科接受中度程序性镇静的成人中比较阿芬太尼与丙泊酚,主要终点为需干预的气道和呼吸不良事件频率。108例完成试验(阿芬太尼52例,丙泊酚56例),主要终点两组相似:阿芬太尼23% vs 丙泊酚20%(p=0.657)。两组均无严重不良事件。次要终点中,疼痛报告率(阿芬太尼48% vs 丙泊酚13%)和回忆率(阿芬太尼75% vs 丙泊酚23%)差异明显,而对操作满意度相似(87% vs 84%)。结论认为两种药物用于中度程序性镇静均似乎安全。
要点
- 急诊成人中度程序性镇静中,阿芬太尼与丙泊酚需干预的气道/呼吸不良事件发生率相似:阿芬太尼23% vs 丙泊酚20%(p=0.657)。
- 两组均无严重不良事件。
- 阿芬太尼组疼痛报告率48% vs 丙泊酚13%,回忆率75% vs 丙酚23%,差异明显。
- 对操作满意度两组相似:阿芬太尼87% vs 丙泊酚84%。
- 作者结论:两种药物用于中度程序性镇静均似乎安全。
适用人群与场景
- 在急诊科接受中度程序性镇静的成人。
研究设计与关键结果
- 研究类型:随机临床试验;108例完成试验,阿芬太尼组52例,丙泊酚组56例。
- 主要终点(需干预的气道和呼吸不良事件频率):阿芬太尼23% vs 丙泊酚20%(p=0.657)。
- 两组均无严重不良事件。
- 疼痛报告率:阿芬太尼48% vs 丙泊酚13%;回忆率:阿芬太尼75% vs 丙泊酚23%。
- 对操作满意度:阿芬太尼87% vs 丙泊酚84%。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,阿芬太尼与丙泊酚用于急诊成人中度程序性镇静时,需干预的气道/呼吸不良事件频率相似,两者均似乎安全。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: To compare the frequency of airway and respiratory adverse events leading to an intervention between moderate sedation using alfentanil or propofol.
METHODS: We performed a randomized clinical trial in which adults undergoing moderate sedation in the ED received either alfentanil or propofol. Our primary outcome was the frequency of airway and respiratory adverse events leading to an intervention. Other outcomes included sedation depth, efficacy, sedation time, patient satisfaction, pain, and satisfaction.
RESULTS: 108 subjects completed the trial: 52 receiving alfentanil and 56 receiving propofol. Airway or respiratory adverse events leading to an intervention were similar between the two groups: 23% for alfentanil and 20% for propofol (p=0.657). There were no serious adverse events in any group. Secondary outcomes were notably different in the rate of reported pain (48% for alfentanil, 13% for propofol) and recall (75% for alfentanil, 23% for propofol) and similar in the rate of satisfaction with the procedure (87% for alfentanil, 84% for propofol).
CONCLUSION: We found a similar frequency of airway and respiratory adverse events leading to intervention between alfentanil and propofol used for moderate procedural sedation. Both agents appear safe for moderate procedural sedation.
参考来源
- Miner JR, Driver BE, Moore JC, et al. Randomized clinical trial of propofol versus alfentanil for moderate procedural sedation in the emergency department. Am J Emerg Med. 2017. PMID: 28438447. doi:10.1016/j.ajem.2017.04.041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。